bioMerieux S.A. buy UBS Group AG
Start price
24.08.24
/
50%
€103.80
Target price
24.08.25
-
Performance (%)
22.64%
End price
25.08.25
€127.30
Summary
This prediction ended on 25.08.25 with a price of €127.30. The prediction had a final performance of 22.64%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| bioMerieux S.A. | -7.257% | -7.257% | -4.554% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by UBS_Group_AG for this prediction
In the thread bioMerieux S.A. diskutieren
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for BMXMF provided by MarketBeat
In the thread Trading bioMerieux S.A.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten